“…Considering its pleiotropic function and nontoxicity, researchers have been increasingly focused on OA and making efforts to improve its activity and drugability in recent decades (Liby Since that cancer-related deaths keep rising both in developed and developing countries in recent years, the anti-tumor property of OA receives more and more attention. Apoptosis induction has been well known as one of the major mechanisms underlying OA anti-tumor activity on various types of cancer cells (Juan et al, 2006;Martin et al, 2007;Zhang et al, 2007;Shyu et al, 2010;Yan et al, 2010;Feng et al, 2011b;Lucio et al, 2011;Pratheeshkumar et al, 2011;Zhou et al, 2011;Chakravarti et al, 2012;George et al, 2012;Gu et al, 2012;Struh et al, 2012;Wei et al, 2012;Wang et al, 2013). Mechanistically, OA treatment increases the ratio of proapoptotic protein, Bax, to anti-apoptotic protein, Bcl-2, in the outer mitochondrial membrane, facilitates the formation of Bax oligomer, increases the permeability of mitochondrial membrane, releases cytochrome C from inner membrane into cytosol, triggers the caspase pathway through activating Apaf-1, cleaves multiple cellular target molecules including Poly ADP ribose polymerase (PARP) and DNA, and eventually leads to cell death (Martin et al, 2007;Zhang et al, 2007;Shyu et al, 2010;Yan et al, 2010;Zhou et al, 2011;Chakravarti et al, 2012;Wei et al, 2012;Wang et al, 2013).…”